Honda, K., Katzke, V. A., Hüsing, A., Okaya, S., Shoji, H., Onidani, K., Olsen, A., Tjønneland, A., Overvad, K., Weiderpass, E., Vineis, P., Muller, D., Tsilidis, K., Palli, D., Pala, V., Tumino, R., Naccarati, A., Panico, S., Aleksandrova, K., Boeing, H., Bueno‐de‐Mesquita, H. B., Peeters, P. H., Trichopoulou, A., Lagiou, P., Khaw, K., Wareham, N., Travis, R. C., Merino, S., Duell, E. J., Rodríguez‐Barranco, M., Chirlaque, M. D., Barricarte, A., Rebours, V., Boutron‐Ruault, M., Romana Mancini, F., Brennan, P., Scelo, G., Manjer, J., Sund, M., Öhlund, D., Canzian, F., & Kaaks, R. (2019). cA19‐9 and apolipoprotein‐A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation. International journal of cancer, 144(8), 1877–1887. http://access.bl.uk/ark:/81055/vdc_100077484050.0x000060